Daniel P. Silver

10.4k citations
39 papers · 8k · 4 hit papers · h-index 29

Impact in

    • Cancer Genomics and Diagnostics
    • Breast Cancer Treatment Studies
  • Oncology top 1%
    • PARP inhibition in cancer therapy
    • Cancer-related Molecular Pathways

Papers in

    • Cancer Genomics and Diagnostics 7
    • Breast Cancer Treatment Studies 5
    • PARP inhibition in cancer therapy 7
    • Cancer-related Molecular Pathways 4

Daniel P. Silver

39 papers receiving 7.8k citations

Daniel P. Silver's Hit Papers

Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer 2016 · 841 citations
8410+5+11Years since publication4008001.2k

Peers

Daniel P. Silver
Comparison fields: 5 of 103
  • Cancer Research 2.5k
  • Oncology 1.9k
  • Genetics 1.7k
  • Molecular Biology 2.5k
  • Reproductive Medicine 251
Replace Zhigang C. Wang with:
Zhigang C. Wang United States
Sari A. Ward United Kingdom
Hannah Farmer United Kingdom
Yi Fei Huang China
Harry Boutselakis United Kingdom
Kerry Fenwick United Kingdom
Fenglin Liu Canada
Kirsten M. Timms United States
Thomas Karn Germany
Peter J. Campbell United Kingdom
Daniel P. Silver relative to Zhigang C. Wang United States Zhigang C. Wang's profile →
Citations per field
00.5×1.5×2×2.3×
Zhigang C. Wang · 1×
Citations per year

Countries citing papers authored by Daniel P. Silver

Since Specialization
Citations

This map shows the geographic impact of Daniel P. Silver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel P. Silver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel P. Silver more than expected).

Fields of papers citing papers by Daniel P. Silver

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel P. Silver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel P. Silver. The network helps show where Daniel P. Silver may publish in the future.

Co-authors

The 25 scholars most cited alongside Daniel P. Silver, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Daniel P. Silver Line = papers co-authored together Daniel P. Silver links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Mutational Processes Molding the Genomes of 21 Breast Cancers
Hit paper breakdown →
20121487
2
Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer
Hit paper breakdown →
2016841
3
Efficacy of Neoadjuvant Cisplatin in Triple-Negative Breast Cancer
Hit paper breakdown →
2010838
4
Complex landscapes of somatic rearrangement in human breast cancer genomes
Hit paper breakdown →
2009670
5 2004668
6 1998502
7 2012499
8 2001246
9 2002236
10 2015232
11 2009192
12
BRCA1, BRCA2, and Rad51 operate in a common DNA damage response pathway.
1999173
13 2009170
14 2001147
15 1993143
16 2010138
17 2012118
18 199589
19 200763
20
p16(INK4a) and p53 deficiency cooperate in tumorigenesis.
200251

About Daniel P. Silver

Daniel P. Silver is a scholar working on Cancer Research, Oncology, Genetics, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 39 papers that have together received 8k indexed citations. Recurring topics across this work include BRCA gene mutations in cancer (12 papers), DNA Repair Mechanisms (7 papers), Cancer Genomics and Diagnostics (7 papers), PARP inhibition in cancer therapy (7 papers), Breast Cancer Treatment Studies (5 papers), Genomics and Chromatin Dynamics (4 papers), Cancer-related Molecular Pathways (4 papers) and Epigenetics and DNA Methylation (3 papers). The work is most often cited by research in Cancer Research (2.5k citations), Oncology (1.9k citations), Genetics (1.7k citations), Molecular Biology (2.5k citations) and Reproductive Medicine (251 citations). Daniel P. Silver has collaborated with scholars based in United States, Denmark and United Kingdom. Frequent co-authors include David M. Livingston, James Dirk Iglehart, Ralph Scully, Nicolai J. Birkbak, Zoltán Szállási, Ronald Anthony DePinho, Andrea L. Richardson, Aron Charles Eklund, Zhigang C. Wang and David Baltimore. Their work appears in journals such as Cell, Clinical Cancer Research, Cancer Discovery, Nature and Breast Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact